BioSpace News Archive

Business

Shanghai Genchem Co., Ltd. (Genechem) Announces Global Collaboration on Bispecific Antibodies

Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel drug target discovery and development of novel therapeutics, today announced the execution of a global collaboration with I-Mab (Nasdaq: IMAB), a Nasdaq-listed global biopharmaceutical company,

April 6, 2021
·
1 min read
Genetown

Dante Labs achieves ISO 13485 certification for its Genomic Interpretation Software Immensa, leveraging an 18 month long clinical validation study of 500,000 samples

Dante Labs, a world leader in genomic sequencing and data analysis, announced that it received ISO 13485:2016 certification for its Immensa Genomic Interpretation Software as a medical device.

April 6, 2021
·
1 min read
Business

Juvenescence Appoints Dr. Grazia Piizzi as Chief Scientific Officer

Juvenescence Limited, a life sciences company focused on modifying aging and increasing human healthspan, announced that Dr. Grazia Piizzi, PhD, has joined its Executive Management Team as Chief Scientific Officer.

April 6, 2021
·
3 min read
OSE Immunotherapeutics Announces First Peer-Reviewed Publication in “Science Advances” on OSE-230, its Novel Monoclonal Antibody Agonist Therapy Triggering Resolution of Chronic Inflammation

OSE Immunotherapeutics announced the first peer-reviewed publication on OSE-230, a novel and innovative approach in the management of the resolution of chronic and severe inflammation, in Science Advances.

April 6, 2021
·
7 min read
Business

Hadassah and MyBiotics to Collaborate for the Discovery of Microbiome-Based Therapy for Improving Cancer Immunotherapy

Collaboration will focus on identifying microbiome therapeutics for enhancing response to and reducing adverse effects of checkpoint inhibitors in melanoma patients

April 6, 2021
·
6 min read
Business

Protera Appoints Novozymes Executive Thomas Videbaek As Chair of the Board of Directors and Non-Executive Board Member

Protera, an AI-driven startup designing and developing new proteins to enable a wide range of natural and sustainable solutions, announced it has appointed Novozymes senior executive Thomas Videbaek as Chair of the Board of Directors and non-executive board member.

April 6, 2021
·
2 min read
Policy

Azafaros Enters Clinical Stage With AZ-3102, an Oral Small Molecule Being Developed for Rare Neurogenetic Disorders

Phase 1 clinical study investigates safety and tolerability, pharmacokinetics and pharmacodynamic effects of first-in-class azasugar AZ-3102 in healthy subjects

April 6, 2021
·
4 min read
BioMidwest

Life Spine, Inc. Announces Preliminary Injunction Prohibiting Sale of Products Found to Be Reverse Engineered From Its ProLift® Expandable Cage

A preliminary injunction preventing the marketing and sale of Aegis Spine, Inc.’s AccelFix-XT line of expandable medical devices is now in effect

April 6, 2021
·
1 min read
Genetown

Belmont Instrument LLC, d.b.a. Belmont Medical Technologies Awarded up to $133M in U.S. Military Contract

Belmont Instrument, LLC, d.b.a. Belmont Medical Technologies (“Belmont”), a leading provider of fluid resuscitation and patient temperature management solutions, was awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) Contract with a potential maximum dollar value of up to $133,570,787

April 6, 2021
·
3 min read
Genetown

Applied BioMath, LLC Launches Software Product for the Early Feasibility Assessment of Biotherapeutics

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, announced today the launch of Applied BioMath Assess™, an early feasibility assessment tool for biotherapeutics.

April 6, 2021
·
3 min read